The SPDR S&P Biotech ETF (ARCA:XBI) is up more than 40% over the past six months and is on the verge of breaking out. Here's ...

The microcap biotech stock had its best day ever after the FDA granted its rare-disease drug a breakthrough designation.

Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest ...

How to trade and invest in the biotech space with ROTY Biotech Community 's Jonathan Faison (0:35). Making money in biotech (5:40). Managing sector risk (9:20). Geron - a stock he never thought he'd ...

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam ...

Galecto stock soars as meme stock enthusiasts flock into the biotech name for no apparent reason. Here’s why GLTO shares are ...

The Tech Team Discarded By Goldman Sachs But Appreciated By Citadel And Citadel Securities (eFinancialCareers) As AI Bubble ...

(RTTNews) - Biotech stocks lit up the after-hours session on September 9, 2025, with several small- and mid-cap names posting sharp gains following fresh clinical updates, insider buying, and investor ...

Galecto stock rockets 600% on retail frenzy, tiny float dynamics, and social media hype, amid high volatility risks.

Novartis said Tuesday it is buying Tourmaline Bio for $1.4 billion in a deal that gives the Swiss pharma giant access to the biotech’s late-stage cardiovascular drug pacibekitug.

NKGen Biotech (NKGN) issued the following statement in response to recent shareholder inquiries regarding its current trading status on the OTC ...